SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CRXX-Combinatorx
An SI Board Since November 2005
Posts SubjectMarks Bans Symbol
100 6 0 CRXX
Emcee:  rkrw Type:  Moderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
25That's the beauty of the system and business plan. Get combos quickly and chrkrw-2/22/2006
24Hi tuck, I meant that about crx-140 for psoriasis indication. Cheers, Praveendr.praveen-2/22/2006
23With the current pipeline my money is on the pred combo's. I haven't seedr.praveen-2/22/2006
22I actually thought it was a pretty nifty idea, take a drug that works for psoriarkrw-2/22/2006
21Which ones? 140 was one of them. 102 is a combo of prednisolone and dipyridamoltuck-2/22/2006
20I agree with you tuck.I found management is very smart after listening to some odr.praveen-2/22/2006
19I like the decision to just drop it. The stock would be getting hurt much more tuck-2/22/2006
18CombinatoRx Discontinues CRx-140 as an Oral Product Candidate For Psoriasis; Tridr.praveen-2/22/2006
17CombinatoRx and Fovea Enter Into Collaboration to Develop Novel Ophthalmic Theranigel bates-1/31/2006
16CombinatoRx Drug Candidate CRx-102 Demonstrates Positive Phase 2 Study Results inigel bates-1/30/2006
15CombinatoRx and Bio*One Capital Establish CombinatoRx Singapore for Infectious Dmopgcw-1/25/2006
14CombinatoRx to Host Analyst Briefing at 8:30 am EST on January 31st, 2006 Wednesmopgcw-1/25/2006
13AG Edwards Starts Combinatorx At Buy (eom)mopgcw-1/10/2006
12quick summary: $85 million in cash; $5mm in debt; burning $20mm a year; thoumopgcw-1/6/2006
11from s-1 pipeline: Immuno-Inflammatory CRx-139 Selective steroidmopgcw-1/6/2006
10I own a little of the stock. But can agree a wait and see approach is smart. Therkrw-12/19/2005
9Thanks for comments Dr. P. I have a wait and see attitude to crxx, with doubts.keokalani'nui-12/19/2005
8I just said that about Nobel Laureates, Not about their management. A few biodr.praveen-12/19/2005
7Welcome aboard, Doc, Appreciate your thoughts. But after coming up with nothintuck-12/18/2005
6Hi wilderelisimo and Board, My opinion on CRXX Management seems very focusseddr.praveen-12/18/2005
5A look at Angiotech's stake (which started out pre-IPO as converts): sec.gotuck-11/18/2005
4Overallotment exercised. >>BOSTON--(BUSINESS WIRE)--Nov. 18, 2005--Combintuck-11/18/2005
3They signed this deal in October. anpi was very enthusiastic on the call. If anyrkrw-11/15/2005
2"Systematic discovery of multicomponent therapeutics" pnas.org From tuck-11/15/2005
1bio-itworld.com By BIO-IT World COMPANY TO WATCH The Odd Couple CombinatoRrkrw-11/15/2005
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News